This session had as its central theme the analysis of peptide epitopes and their relationship with lupus pathogenesis. New information on the role of peptides opens up the possibility of treatments based on inducing immunological tolerance although care needs to be taken since it is diffi cult to predict flare or remission of disease after exposure to critical antigenic peptides. The provenance of these peptides may be self or foreign antigens, or autoantibody idiotypes.
Kaliyaperumal A , Michaels MA , Datta SK . Naturally processed chromatin peptides reveal a major autoepitope that primes pathogenic T and B cells of lupus . J Immunol2002; 168: 2530–2537 .
2.
Riemekasten G , Marell J , Trebeljahr G , Klein R , Hausdorf G , Haupl T , Schneider-Mergener J , Burmester GR , Hiepe F . A novel epitope on the C-terminus of SmD1 is recognized by the majority sera from patients with systemic lupus erythematosus . J Clin Invest1998; 102: 754–763 .
3.
Odendahl M , Jacobi A , Hansen A , Feist E , Hiepe F , Burmester GR , Lipsky PE , Radbruch A , Dorner T . Disturbed peripheral B lymphocyte homeostasis in systemic lupus erythematosus . J Immunol2000; 165: 5970–5979 .
4.
Bredholt G , Olaussen E , Moens U , Rekvig OP . Linked production of antibodies to mammalian DNA and to human polyomavirus large T antigen footprints of a common molecular and cellular process?Arthritis Rheum1999; 42: 2583–2592 .
5.
Hahn BH , Singh RR , Wong WK , Tsao BP , Bulpitt K , Ebling FM . Treatment with a consensus peptide based on amino acid sequences in autoantibodies prevents T cell activation by autoantigens and delays disease onset in murine lupus . Arthritis Rheum2001; 44: 432–441 .
